ABSTRACT
Objective A comprehensive overview of the research output, including conceptual and temporal trends, is required to address the growing AMR burden in Nigeria, which was previously lacking. This study uses bibliometric analysis to show this.
Methods Data from a query of AMR articles in the Dimensions database (PubMed included) were subjected to bibliometric analysis (1972–2022). Bibliometric indicators, topic networks were established and topic trends were analysed by frequency, relevance scores, and trends over time.
Results A total of 0.2% of the papers on AMR published worldwide were written by authors or institutions from Nigeria. In 2021, publications grew by 13.6%, highlighting the field’s increased vigour. The vast majority of publications (57.18%) were in the field of Medical and Health Sciences, with 2428 papers. The top journal for AMR papers with at least one Nigerian institution affiliation was African Journal of Clinical and Experimental Microbiology, which published 1.8% of these papers. Antimicrobial stewardship, Clinical and laboratory practices on AMR, Public health implications, Traditional and molecular methods, and Phytomedicine and drug discovery were prominent areas of focus for Nigerian researchers.
Conclusion This study provides a comprehensive overview of the AMR research output, highlighting the need of increased research capacity to address the burden of AMR in Nigeria. Because Nigeria is overly reliant on conventional methods of discovery and development, innovation is essential for the future of antibiotics.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any funding
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
All data produced in the present study are available upon reasonable request to the authors